Skip to main content
. 2023 Mar 22;14:1577. doi: 10.1038/s41467-023-36984-1

Fig. 1. Overview of study cohort.

Fig. 1

Nasal/oropharyngeal/saliva swabs for PCR, mucosal antibody analysis12 and serum were collected at enrolment (baseline). Participants who tested qPCR positive at enrolment (n = 21) were excluded from all analyses except for estimation of cumulative incidence. Self-administered nasal/oropharyngeal/saliva swabs for qPCR were collected twice weekly for 4 weeks or until positive qPCR test from participants who tested qPCR negative at enrolment (n = 347). Participants who subsequently tested qPCR positive during the screening program (n = 60) were enrolled in an extended program comprising self-administered nasal/oropharyngeal/saliva swabs for qPCR every other day for 15 days.